Edition:
United States

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

53.30USD
11:47am EDT
Change (% chg)

$-1.52 (-2.77%)
Prev Close
$54.82
Open
$54.97
Day's High
$54.97
Day's Low
$52.95
Volume
9,236
Avg. Vol
46,087
52-wk High
$68.91
52-wk Low
$15.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.89 December 22 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 1
(3) HOLD 0 0 0 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.20 0.50 0.00 0.00
Year Ending Dec-19 5 10.02 31.10 0.00 14.75
Earnings (per share)
Quarter Ending Jun-18 5 -0.89 -0.80 -1.00 -0.38
Quarter Ending Sep-18 5 -0.94 -0.85 -1.01 -0.40
Year Ending Dec-18 5 -3.72 -3.40 -3.95 -1.78
Year Ending Dec-19 5 -4.26 -2.26 -6.63 -2.13

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.48 0.48 0.00
Quarter Ending Dec-17 0.00 0.33 0.33 0.00
Quarter Ending Sep-17 5.75 7.81 2.06 35.86
Quarter Ending Jun-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.20 0.20 0.20 0.00 0.00
Year Ending Dec-19 10.02 10.02 10.02 6.02 14.75

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings